- Pharmaceutical companies
- Europe
- Austria
- Alexion Pharmaceuticals
Alexion Pharmaceuticals in Austria
Web: https://alexion.com/worldwide/Austria
Address:
-
Alexion Pharma Austria GmbH
Landstraßer Hauptstraße 1A, 1030 Wien, Austria
Phone: +43 4445 74000
Fax: 43 1253 6722 8214
Other Alexion Pharmaceuticals's locations around the world
Clinical Trials sponsored by Alexion Pharmaceuticals
-
Alexion PharmaceuticalsComplétéHémoglobinurie paroxystique nocturneRoyaume-Uni
-
Alexion PharmaceuticalsComplété
-
Alexion PharmaceuticalsComplétéHémoglobinurie paroxystique nocturne | PNHCorée, République de, Canada, France, Allemagne, Espagne, Taïwan, Royaume-Uni
-
Alexion PharmaceuticalsComplété
-
Alexion PharmaceuticalsComplétéMaladie de WilsonÉtats-Unis, Allemagne, L'Autriche, Pologne, Royaume-Uni
-
Alexion PharmaceuticalsComplété
-
Alexion PharmaceuticalsComplétéDéficit en lipase acide lysosomaleFrance, Pologne, Royaume-Uni, Espagne, Mexique, Turquie, Japon, Australie, Fédération Russe, États-Unis, Allemagne, Italie, Tchéquie, Argentine, Croatie
-
Alexion PharmaceuticalsRetiré
-
Alexion PharmaceuticalsComplétéMyasthénie grave généralisée réfractaireItalie, Royaume-Uni, Espagne, Belgique, Turquie, Japon, États-Unis, Pays-Bas, Corée, République de, Argentine, Hongrie, Suède, Danemark, Brésil, Tchéquie, Finlande, Canada
About Alexion Pharmaceuticals
People living with rare and devastating diseases are our Guiding Star. We believe it is our responsibility to listen to, understand, and change the lives of patients and those who work tirelessly to help them. To transform the lives of people affected by rare diseases and devastating conditions by continuously innovating and creating meaningful value in all that we do. And we’re making real progress, every day. We continue to deepen our understanding of rare disease, which began with our pioneering work in complement biology. This knowledge allows us to innovate and evolve into new areas, where there is great unmet need and opportunity to help patients and families fully live their best lives. We’ve delivered transformative medicines for people with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), anti-aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD), generalized Myasthenia Gravis (gMG), hypophosphatasia (HPP), and lysosomal acid lipase deficiency (LAL-D). We invest in and value people who believe in the importance of our purpose and understand what it takes to deliver on it. Our culture is rooted in integrity, inclusiveness, and our dedication to joining and supporting the communities in which we live and work. At Alexion, our passion drives us to continuously innovate and create meaningful value in all we do. In doing so, we change lives for the better – ours, people living with rare diseases, and the communities we serve. Every day.